Reuters logo
BRIEF-Horizon Pharma says FDA approved to expand age range for Ravicti
2017年5月1日 / 上午11点26分 / 5 个月前

BRIEF-Horizon Pharma says FDA approved to expand age range for Ravicti

May 1 (Reuters) - Horizon Pharma Plc-

* Horizon Pharma Plc announces FDA approval to expand the age range for Ravicti® (glycerol phenylbutyrate) oral liquid to people with urea cycle disorders two months of age and older Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below